The Competition Commission approved the merger of nine entities with the pharmaceutical company Sequent Scientific Ltd (SSL). "The suggested merger entails a sequence of linked actions executed for the integration of SRL, Viyash, Symed, Appcure...
Glenmark Pharmaceuticals announced that its US division has introduced the anticoagulant Phytonadione injectable emulsion. Glenmark Pharmaceuticals Inc., USA has introduced a 10 mg/mL injectable emulsion of Phytonadione in single-dose ampules...
InnoCare Pharma and KeyMed Biosciences announced that they, along with their joint venture, have collectively signed an exclusive licensing agreement with Prolium Bioscience (Prolium) for the advancement and marketing of ICP-B02 (CM355)...
GSK plc announced that the European Commission has authorized Jemperli (dostarlimab) in conjunction with chemotherapy (carboplatin and paclitaxel) as a first-line therapy for adult patients with primary advanced or recurrent endometrial cancer...
SCHOTT Pharma, a leader in drug containment and delivery solutions, introduces the next generation of SCHOTT TOPPAC infuse polymer syringes, a system aimed at enhancing safety, efficiency, and sustainability in the healthcare sector. Created in...
Indian pharmaceutical experts anticipate positive trade conditions with Donald Trump assuming the presidency of the US. The United States continues to be an important market for Indian pharmaceutical firms, representing roughly 30% of India's...
Strides Pharma Science Limited has announced that its wholly owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has obtained approval from the United States Food & Drug Administration (USFDA) for Acetaminophen and Ibuprofen Tablets...
Amgen announced that the US Food and Drug Administration (FDA) has granted approval for Lumakras (sotorasib) in conjunction with Vectibix (panitumumab) for treating adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC)...
Guangzhou Fermion Technology Co., Ltd., an AI-focused biotech firm in clinical development, and Simcere Pharmaceutical Group Limited, a pharmaceutical entity, have announced a collaboration to advance a clinical-stage pain treatment asset, FZ002...
AstraZeneca's Calquence (acalabrutinib), combined with bendamustine and rituximab, has received approval in the US for treating adult patients with previously untreated mantle cell lymphoma (MCL) who cannot undergo autologous hematopoietic stem...
, CDSCO.jpg)
